首页 | 本学科首页   官方微博 | 高级检索  
     

包封硫酸依替米星壳聚糖/羟基磷灰石纳米缓释骨支架的实验研究
引用本文:弓家弘,王静成,王大新,杨伟霞. 包封硫酸依替米星壳聚糖/羟基磷灰石纳米缓释骨支架的实验研究[J]. 中华骨科杂志, 2011, 31(12): 1374-1381. DOI: 10.3760/cma.j.issn.0253-2352.2011.12.014
作者姓名:弓家弘  王静成  王大新  杨伟霞
作者单位:1. 江苏省苏北人民医院骨科,扬州,225001
2. 生物医学工程中心,扬州,225001
3. 临床医学检验中心,扬州,225001
摘    要: 目的 研制一种包封硫酸依替米星壳聚糖/羟基磷灰石纳米缓释骨支架, 为临床治疗骨缺 损、骨髓炎提供一定帮助。方法 离子凝胶法制作载硫酸依替米星的壳聚糖颗粒, 载药颗粒结合纳米级 羟基磷灰石于模具中成形, 采用冻干成孔法制备多孔缓释载药纳米骨支架。使用扫描电子显微镜观察 支架表面及其研碎颗粒、X线多晶衍射检测判断其组成、总孔隙率测定以了解其相关表征;进行抑菌实 验及长期和累计释药实验了解骨支架抗菌性及缓释性;最后通过骨髓间质干细胞与支架共培养, 检测 支架的组织相容性。结果 载药纳米骨支架为多孔圆柱形颗粒, 电镜下其具有纳米级球棒状微观结构, 材料表面及内部孔隙分布良好, 总孔隙率为 70.68%, X线多晶衍射为典型羟基磷灰石波形;抗菌性实验 中其抑菌效果可维持 1周以上, 7d后仍有药物释出;对骨髓间质干细胞无明显抑制作用。结论 包封 硫酸依替米星壳聚糖/羟基磷灰石纳米缓释骨支架具有与松质骨类似的孔隙结构及组成成分, 良好的缓 释抗菌效果, 可降解, 组织相容性好, 是较有前景的人工骨替代材料。

关 键 词:壳聚糖  羟基磷灰石类  氨基糖苷类  组织工程
收稿时间:2010-11-15;

Preparation, characterization and in vitro analysis of etimicin-encapsuled chitosan/hydroxyapatite nano-scaffolds for bone tissue engineering
GONG Jia-hong,WANG Jing-cheng,WANG Da-xin,YA NG Wei-xia. Preparation, characterization and in vitro analysis of etimicin-encapsuled chitosan/hydroxyapatite nano-scaffolds for bone tissue engineering[J]. Chinese Journal of Orthopaedics, 2011, 31(12): 1374-1381. DOI: 10.3760/cma.j.issn.0253-2352.2011.12.014
Authors:GONG Jia-hong  WANG Jing-cheng  WANG Da-xin  YA NG Wei-xia
Affiliation:*Department of Orthopaedics, Subei People's Hospital of Jiangsu Province, Yangzhou 225001, China
Abstract:Objective To prepare a novel etimicin-encapsuled chitosan/hydroxyapatite nano-scaffolds and offer assistances for bone defect or osteomylitis.Methods Drug-carried chitosan nanoparticles which was prepared by ionotropic gelation were combined with nano-hydroxyapatite.The mixture were shaped in molds and then prepared into porous scaffolds by freeze-dry.The surface of one scaffold was scanned.The grinded,particles of the scaffold were detected by field emission scanning electron microscope; X-ray diffraction was used to analyze components of the scaffold and total porosity.Staphylococcus aureus was choosed as the experimental bacteria,we studied lasting antibacterial property of drug-carried bone scaffold by antibacterial experiments,long-term drug releasing experiments and accumulation drug releasing experiments.Bone mesenchymal stem cells were used to detect the histocompatibility and inductivity of etimicin-carried scaffold.Results Freeze-dried porous scaffold has a surface with proper pore distribution (total porosity 70.68%) and the grinded scaffold has a globular and coliformed microstructure known after scanned by electron microscope.The drug-carried scaffold has a typical wave of hydroxyapatite under X-ray diffraction.The lasting antibacterial property study indicated that the drug-carried bone scaffold had maintained an inhibition zone for more than 7 days.The long-term drug releasing experiments and accumulation drug releasing experiments show that the fictional drug-carried bone scaffold released above the bacteriostasis concentration after one week and the accumulative amount within the safety scale.The scaffold had not an inhibitory effect on bone mesenchymal stem cells.Conclusion The etimicin-encapsuled chitosar/ hydroxyapatite nano-scaffolds has similar microstructure and components of bone tissue.It is promising in bone tissue engineering applications because of its slow-release,antibacterial properties and satisfactory histocompatibility.
Keywords:Chitosan  Hydroxyapatites  Aminoglycosides  Tissue engineering
本文献已被 万方数据 等数据库收录!
点击此处可从《中华骨科杂志》浏览原始摘要信息
点击此处可从《中华骨科杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号